Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2281 - 2288 of 11617 results
Is COVID-19 a Disability? Answer: Sometimes
December 17, 2021| Blog| Viewpoint
New York City Releases Private Employer Vaccine Executive Order
December 16, 2021| Blog| Viewpoint
The Shrinking Scope of Confidentiality: California Extends Confidentiality Ban to All FEHA Protected Classes
December 15, 2021| Blog| Viewpoint
Vaccinated or Not - California’s Indoor Mask Mandate Resumes
December 15, 2021| Blog| Viewpoint
Lawsuits Unlikely To Derail Banks’ Board Diversity Efforts
December 15, 2021| News
DOJ SEP Policy Would Impede or Speed up Negotiations
December 15, 2021| News
California Court Deals Blow to Employee Mobility
December 14, 2021| Blog| Viewpoint
CRITICAL ALERT: Log4Shell
December 13, 2021| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.